Risk of Liver Injury With Potentially Hepatotoxic Drugs-Reply

被引：0
|
作者：
Lo Re III, Vincent [1 ,2 ]
Torgersen, Jessie [1 ,2 ]
Justice, Amy C. [3 ,4 ,5 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Ctr Real World Effectiveness & Safety Therapeut, 423 Guardian Dr,836 Blockley Hall, Philadelphia, PA 19104 USA
[3] US Dept Vet Affairs, VA Connecticut Healthcare Syst, West Haven, CT USA
[4] Yale Sch Med, Dept Med, New Haven, CT USA
[5] Yale Univ, Sch Publ Hlth, Div Hlth Policy & Management, New Haven, CT 06510 USA
来源：
JAMA INTERNAL MEDICINE | 2025年 / 185卷 / 01期
关键词：
D O I：
10.1001/jamainternmed.2024.5489
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [1] Risk of Liver Injury With Potentially Hepatotoxic Drugs
    Bjornsson, Einar S.
    JAMA INTERNAL MEDICINE, 2025, 185 (01)
  • [2] RISK OF SEVERE ACUTE LIVER INJURY AMONG INITIATORS OF POTENTIALLY HEPATOTOXIC DRUGS
    Mezochow, Alyssa
    Torgersen, Jessie
    Newcomb, Craig W.
    Carbonari, Dena
    Hennessy, Sean
    Park, Lesley S.
    Mehta, Rajni
    Tate, Janet P.
    Taddei, Tamar H.
    Justice, Amy C.
    Lo Re, Vincent, III
    HEPATOLOGY, 2020, 72 : 87A - 88A
  • [3] Review article: the use of potentially hepatotoxic drugs in patients with liver disease
    Gupta, N. K.
    Lewis, J. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (09) : 1021 - 1041
  • [4] The frequency of drug-induced liver injury (DILI) among patients receiving potentially hepatotoxic drugs: a population based study
    Bjornsson, Einar
    Bergmann, Ottar
    Bjornsson, Helgi K.
    Olafsson, Sigurdur
    HEPATOLOGY, 2012, 56 : 594A - 595A
  • [5] Little Evidence for Serious Outcome in Patients With Chronic Liver Disease Receiving Potentially Hepatotoxic Drugs
    Bjornsson, Einar
    Einarsdottir, Rannveig
    Jacobsen, Elin
    Chalasani, Naga P.
    GASTROENTEROLOGY, 2014, 146 (05) : S711 - S711
  • [6] Use of Hepatotoxic Drugs in Chronic Liver Disease
    Hug, Balthasar L.
    Surber, Christian
    Bates, David W.
    JOURNAL OF PATIENT SAFETY, 2012, 8 (02) : 45 - 50
  • [7] Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: Results of a European case-control study
    Follmann, M
    Heinemann, LAJ
    Bauerfeind, A
    Garbe, E
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2000, 9 (05) : 417 - 422
  • [8] THE HEPATOTOXIC EFFECTS OF ANAESTHETIC DRUGS - HALOTHANE AND THE LIVER
    SHERLOCK, S
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1964, 57 (04): : 305 - 307
  • [9] EFFECT OF HEPATOTOXIC DRUGS ON LIVER TISSUE CULTURE
    DUJOVNE, CA
    LAVELLE, G
    WEISS, P
    BIANCHINE, J
    LASAGNA, L
    PHARMACOLOGIST, 1969, 11 (02): : 282 - +
  • [10] Meta-analysis of antidepressant effects of anti-inflammatory drugs-reply
    Kohler-Forsberg, O.
    Benros, M. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 140 (04) : 385 - 386
12345